# PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

> **NCT02675114** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 1000 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **PROCEDURE:** SAVR
- **DEVICE:** SAPIEN 3 THV

## Key facts

- **NCT ID:** NCT02675114
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-03
- **Primary completion:** 2020-11-16
- **Final completion:** 2029-12
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675114, "PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02675114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*